Cancer patients with high muscle strength and cardiorespiratory fitness (CRF) had a significantly lower risk of death from any cause, including those with advanced cancers, a large retrospective ...

Five-year data shows lasting benefit for patients with advanced gastroesophageal cancers treated with nivolumab and chemotherapy.

Nearly half of patients with advanced ovarian cancer treated with first-line poly-ADP-ribose polymerase (PARP) inhibitors experienced recurrence in this real-world study, emphasizing the need for ...

Parents vaccinated against COVID-19 were almost twice as likely to vaccinate their child against measles, mumps and rubella compared with unvaccinated parents, according to a study published in ...

Researchers suspect unmet treatment needs contribute to the shorter life expectancy for patients living with attention-deficit/hyperactivity disorder (ADHD).

Nivolumab plus chemotherapy improved long-term survival in Chinese patients with advanced gastric, GEJ, or esophageal cancer.

The phase 3 CheckMate 649 trial showed that nivolumab plus chemotherapy significantly improved long-term overall survival in Chinese patients with advanced gastric, gastroesophageal junction, and ...

CheckMate 649 trial showed sustained efficacy with frontline nivolumab plus chemotherapy vs chemotherapy alone in patients with gastric cancers.

Increased intake of calcium and dairy reduced the risk for colorectal cancer, a prospective cohort analysis published in Nature Communications revealed.In comparison, the consumption of other certain ...

As the Texas Legislature moves past its second week of the 89th session, The Woodlands Township board of directors is looking to amend its enabling legislation in an effort to allow the township ...

The Food and Drug Administration (FDA) has approved Grafapex ™ (treosulfan) for injection with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

A study of nearly 1,000 people with post-COVID-19 syndrome (PCS) revealed that two-thirds still experienced significant symptoms, including reduced exercise capacity and cognitive performance, two ...